Form 8-K · Current Report · Filed 2026-02-05
IQVIA Reports Strong 2025 Results and Provides 2026 Guidance
IQVIA Holdings Inc. reported financial results for the fourth-quarter and full-year 2025, showing revenue of $4,364 million for Q4 and $16,310 million for the full year. GAAP net income was $514 million for Q4 and $1,360 million for the full year. Adjusted EBITDA was $1,046 million for Q4 and $3,788 million for the full year. The company also provided guidance for the full-year 2026, expecting revenue between $17,150 million and $17,350 million. Additionally, IQVIA announced changes to its segment reporting effective January 1, 2026.
- Filer
- Iqvia Holdings Inc. IQV · NYSE
- Filed
- Accession
- 0001628280-26-005605
- CIK
- 0001478242
- Signal
- High impactHealthcare
- Source
- Official filing on sec.gov ↗
Items reported
Reported Item
Market reaction
Close before filing
$202.54
Next session
-7.4%
Since filing
+16.0%
Latest close
$235.02
What happened, not what will happen — closing prices around the filing date.
About Iqvia Holdings Inc.
Iqvia Holdings Inc. is a leading global provider of advanced analytics, technology solutions, and contract research services. Its primary function is to support the healthcare sector by offering data-driven insights and innovations that underpin strategic decision-making across pharmaceutical, biotechnology, and medical device industries. Iqvia plays a crucial role in facilitating drug development through its comprehensive clinical research capabilities, encompassing everything from clinical trials to regulatory submissions. Additionally, its technology solutions leverage artificial intelligence and machine learning to optimize clinical and commercial operations, contributing to enhanced patient outcomes and streamlined healthcare delivery. Iqvia's integrated services impact sectors such as drug safety, patient engagement, and real-world evidence, making it an indispensable partner for healthcare companies seeking to navigate complex markets and regulatory environments. Globally recognized for its vast data repository and cutting-edge analytical platforms, Iqvia serves as a pivotal player in the transformation of the healthcare landscape, empowering organizations to accelerate innovation and improve patient care.
Never miss another IQV filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.